Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153
Authors
Keywords
Heart, T cells, Apoptosis, Flow cytometry, Antigen-presenting cells, Inflammation, Immunohistochemistry techniques, Necrotic cell death
Journal
PLoS One
Volume 10, Issue 4, Pages e0124059
Publisher
Public Library of Science (PLoS)
Online
2015-04-23
DOI
10.1371/journal.pone.0124059
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SGK-1 Regulates Inflammation and Cell Death in the Ischemic-Reperfused Heart: Pressure-Related Effects
- (2014) B. Baban et al. AMERICAN JOURNAL OF HYPERTENSION
- Programmed Death Ligand 1 Regulates a Critical Checkpoint for Autoimmune Myocarditis and Pneumonitis in MRL Mice
- (2014) J. A. Lucas et al. JOURNAL OF IMMUNOLOGY
- PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1
- (2013) Sheetal Bodhankar et al. Journal of Neuroinflammation
- Pressure Overload Regulates Expression of Cytokines, γH2AX, and Growth Arrest- and DNA-Damage Inducible Protein 153 via Glycogen Synthase Kinase-3β in Ischemic-Reperfused Hearts
- (2012) Babak Baban et al. HYPERTENSION
- PD-1 Protects against Inflammation and Myocyte Damage in T Cell-Mediated Myocarditis
- (2012) M. L. Tarrio et al. JOURNAL OF IMMUNOLOGY
- C/EBP Homologous Protein Deficiency Attenuates Myocardial Reperfusion Injury by Inhibiting Myocardial Apoptosis and Inflammation
- (2011) Yuji Miyazaki et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Impairment of the Programmed Cell Death-1 Pathway Increases Atherosclerotic Lesion Development and Inflammation
- (2011) De-xiu Bu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cancer Immunotherapy Comes of Age
- (2011) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Physiologic Control of IDO Competence in Splenic Dendritic Cells
- (2011) B. Baban et al. JOURNAL OF IMMUNOLOGY
- Programmed Death-1 Pathway Limits Central Nervous System Inflammation and Neurologic Deficits in Murine Experimental Stroke
- (2011) Xuefang Ren et al. STROKE
- The PD-1 pathway in tolerance and autoimmunity
- (2010) Loise M. Francisco et al. IMMUNOLOGICAL REVIEWS
- New therapy to revert dysfunctional antibody responses during HIV-1 infection
- (2010) Francesca Chiodi JOURNAL OF CLINICAL INVESTIGATION
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inhibition of leukotriene C4 action reduces oxidative stress and apoptosis in cardiomyocytes and impedes remodeling after myocardial injury
- (2010) Ulrich M. Becher et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells
- (2009) B. Baban et al. JOURNAL OF IMMUNOLOGY
- Tissue-Specific Differences in PD-1 and PD-L1 Expression during Chronic Viral Infection: Implications for CD8 T-Cell Exhaustion
- (2009) S. D. Blackburn et al. JOURNAL OF VIROLOGY
- PD-L1/PD-1 Signal Deficiency Promotes Allogeneic Immune Responses and Accelerates Heart Allograft Rejection
- (2008) Weigang Wang et al. TRANSPLANTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started